Malaga Cove Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Malaga Cove Capital’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-84,747	Closed	-$1.52M	–	156
2017 Q4	$1.52M	Buy	84,747 +506	+0.6%	+$6.23K	0.85%	40
2017 Q3	$1.02M	Hold	84,241	–	–	0.58%	53
2017 Q2	$882K	Sell	84,241 -28	-0%	-$285	0.53%	61
2017 Q1	$897K	Buy	84,269 +44,384	+111%	+$515K	0.54%	61
2016 Q4	$545K	Buy	+39,885	New	+$556K	0.36%	80

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Malaga Cove Capital's SCMP Position: Q1 2018 in Review

Malaga Cove Capital sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 84,747 shares — an estimated $1.52M sold.

Malaga Cove Capital first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $1.52M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Malaga Cove Capital reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Malaga Cove Capital sold 84,747 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.52M.
Malaga Cove Capital first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
Malaga Cove Capital's Sucampo Pharmaceuticals, Inc. position peaked at $1.52M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Malaga Cove Capital's 13F filing for Q1 2018, filed 16 Apr 2018.